Mechanisms of liver involvement in systemic disease
- PMID: 24090936
- DOI: 10.1016/j.bpg.2013.08.002
Mechanisms of liver involvement in systemic disease
Abstract
The liver may be injured during the course of many systemic diseases. The mechanisms of injury can be broadly divided into four pathways: vascular, toxic, immune, and hormonal. Vascular obstruction may be an early event but is also the late common pathway from all mechanisms. Despite the large number of possible initiating factors, the end results are few, including death of hepatocytes or cholangiocytes, leading to the stereotyped syndromes of acute liver failure, non-cirrhotic portal hypertension, or cirrhosis. This small number of outcomes is a reflection of the few anatomic patterns that can be generated by microvascular obstruction. Vascular obstruction may occur by thrombosis, inflammation, or congestive injury. The innate immunity pathway is activated by endotoxin and other agents, leading to inflammatory infiltration, release of cytokines and reactive oxygen species, and necrosis. The adaptive immune pathway involves the generation of antibodies and antigen-specific cell-mediated attack on hepatic cells. Hormonal effects are principally involved when overnutrition leads to hyperinsulinemia followed by hepatocellular necrosis.
Keywords: Apoptosis; Cytokines; Hyperinsulinism; Hypertension, portal; Immunity, adaptive; Immunity, innate; Liver cirrhosis; Liver ischaemia; Obesity; Reactive oxygen species.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.Z Gastroenterol. 2007 Jan;45(1):63-70. doi: 10.1055/s-2006-927397. Z Gastroenterol. 2007. PMID: 17236122 Review.
-
Acute liver failure: mechanisms of immune-mediated liver injury.Liver Int. 2010 Jul;30(6):782-94. doi: 10.1111/j.1478-3231.2010.02262.x. Epub 2010 May 20. Liver Int. 2010. PMID: 20492514 Review.
-
Hepatic fibrosis, stellate cells, and portal hypertension.Clin Liver Dis. 2006 Aug;10(3):459-79, vii-viii. doi: 10.1016/j.cld.2006.08.017. Clin Liver Dis. 2006. PMID: 17162223 Review.
-
Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases.J Gastroenterol Hepatol. 2009 Dec;24(12):1847-51. doi: 10.1111/j.1440-1746.2009.05916.x. J Gastroenterol Hepatol. 2009. PMID: 19686414
-
Pathophysiology and a Rational Basis of Therapy.Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159267
Cited by
-
Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities.Int J Mol Sci. 2016 Mar 29;17(4):465. doi: 10.3390/ijms17040465. Int J Mol Sci. 2016. PMID: 27043533 Free PMC article. Review.
-
Use of Oral N-Acetylcysteine (NAC) in Non-Acetaminophen-Induced Acute Hepatic Failure.Cureus. 2023 Mar 7;15(3):e35852. doi: 10.7759/cureus.35852. eCollection 2023 Mar. Cureus. 2023. PMID: 37033589 Free PMC article.
-
Understanding infection susceptibility in patients with acute-on-chronic liver failure.Intensive Care Med. 2014 Sep;40(9):1363-6. doi: 10.1007/s00134-014-3349-x. Epub 2014 Jun 6. Intensive Care Med. 2014. PMID: 24902795 Review. No abstract available.
-
Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological Data.Toxicol Sci. 2019 Dec 1;172(2):316-329. doi: 10.1093/toxsci/kfz189. Toxicol Sci. 2019. PMID: 31504990 Free PMC article.
-
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.Front Endocrinol (Lausanne). 2023 Aug 15;14:1139692. doi: 10.3389/fendo.2023.1139692. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37654571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
